Cart (0 Items)
Your cart is currently empty.
View Products
| Size | 96T |
|---|---|
| Brand | ProteoGenix |
| Product type | Elisa assay kits |
| Product name | Orforglipron ELISA Kit |
|---|---|
| Delivery condition | Blue ice (+4°C) |
| Delivery lead time in business days | 3-5 days if in stocks, 3-5 weeks if production is needed |
| Storage condition | 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles |
| Brand | ProteoGenix |
| Aliases /Synonyms | LY3502970, OWL 833, OWL833, OWL-833 |
| Note | For research use only. |
| Immunogen | Orforglipron |
| Assay type | Quantitative |
| Detection method | Colorimetric |
| Recovery | 80-120% |
The Orforglipron ELISA Kit is a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) kit that is designed for the quantitative detection of Orforglipron in various biological samples. The kit is composed of several components including microtiter plates, enzyme conjugate, standards, controls, and a chromogenic substrate.
The microtiter plates are coated with a monoclonal antibody that specifically binds to Orforglipron. This antibody is highly specific and does not cross-react with other compounds, ensuring accurate and reliable results. The enzyme conjugate is a horseradish peroxidase (HRP) enzyme that is conjugated to a secondary antibody. This secondary antibody recognizes and binds to the Orforglipron-antibody complex formed on the microtiter plates.
The standards and controls included in the kit are used to generate a standard curve and validate the assay. The standards are known concentrations of Orforglipron, while the controls are samples with known Orforglipron levels. These are used to determine the sensitivity and accuracy of the assay.
The chromogenic substrate is added to the microtiter plates after the reaction between the secondary antibody and the Orforglipron-antibody complex. The substrate is converted by the HRP enzyme into a colored product, which is directly proportional to the amount of Orforglipron present in the sample. The intensity of the color is measured using a spectrophotometer, and the Orforglipron concentration in the sample is calculated based on the standard curve.
The Orforglipron ELISA Kit has been shown to have a high sensitivity and specificity for the detection of Orforglipron. It has a detection range of 0.1-10 ng/mL, making it suitable for a wide range of applications. The kit has a low limit of detection, with a minimum detectable dose of 0.01 ng/mL, allowing for the detection of even low levels of Orforglipron in biological samples.
The activity of the Orforglipron ELISA Kit is based on the principle of competitive ELISA. The microtiter plates are coated with a limited amount of the specific monoclonal antibody, which binds to the Orforglipron present in the sample. The addition of the enzyme conjugate and the chromogenic substrate results in the competition between the Orforglipron in the sample and the Orforglipron in the standards or controls for binding to the antibody. The intensity of the color produced is inversely proportional to the amount of Orforglipron present in the sample, allowing for the quantification of Orforglipron levels.
The Orforglipron ELISA Kit has several applications in both research and clinical settings. As a highly sensitive and specific assay, it is widely used for the quantitative detection of Orforglipron in various biological samples, including serum, plasma, and tissue homogenates. It is a valuable tool for studying the pharmacokinetics and pharmacodynamics of Orforglipron, as well as for monitoring drug levels in patients receiving Orforglipron therapy.
Furthermore, the Orforglipron ELISA Kit is also used in preclinical and clinical studies to evaluate the efficacy of new Orforglipron-based therapies. It is an essential tool for drug discovery and development, allowing researchers to accurately measure the levels of Orforglipron in biological samples and assess the effects of different treatments.
In addition to its research applications, the Orforglipron ELISA Kit also has potential clinical applications. It can be used for the diagnosis and monitoring of diseases that are associated with altered Orforglipron levels, such as diabetes and obesity. The kit can also be used for therapeutic drug monitoring, ensuring that patients are receiving the appropriate dose of Orforglipron for their condition.
In conclusion, the Orforglipron ELISA Kit is a highly sensitive and specific assay that is essential for the accurate and reliable detection of Orforg
Send us a message from the form below
Reviews
There are no reviews yet.